VALGENT : Validation of HPV genotyping tests potentially usable in cervical cancer screening
VALGENT is a study framework for test comparison and validation of HPV assays in general and HPV genotyping tests in particular according to clinically relevant outcomes and for clinical applications endorsed by scientific evidence.
A dozen of HPV assays have been evaluated using archived cervical cytology specimen collected in the framework of the cervical cancer screening programmes in Belgium, Scotland, Slovenia and Denmark.
Gerelateerde artikelen :
Clinical Evaluation of INNO-LiPA HPV Genotyping EXTRA II Assay Using the VALGENT Framework
Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework